Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals LtdfiledCriticalGlenmark Pharmaceuticals Ltd
Priority to MX2013003022ApriorityCriticalpatent/MX366763B/en
Publication of MX2013003022ApublicationCriticalpatent/MX2013003022A/en
Publication of MX366763BpublicationCriticalpatent/MX366763B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The patent application refers to pharmaceutical compositions of fixed doses for oral administration, which comprises montelukast or salts thereof and levocetirizine or the salts thereof.
MX2013003022A2013-03-152013-03-15PHARMACEUTICAL COMPOSITIONS OF MONTELUKAST and LEVOCETIRIZINE.
MX366763B
(en)